Interleukin-23 and Th17 cells in transplantation immunity: Does 23+17 equal rejection?

被引：47

作者：

Chen, Ye ^{[1
]}

Wood, Kathryn J. ^{[1
]}

机构：

[1] Univ Oxford, Transplant Res Immunol Grp, Nuffield Dept Surg, Oxford, England

来源：

TRANSPLANTATION | 2007年 / 84卷 / 09期

关键词：

IL-17; IL-23; IL-6; TGF beta; IL-12; interferon gamma; cytokine; transplantation; rejection; tolerance; allograft; ischemia reperfusion injury; Th17; Th1; Th2; ROR gamma T;

D O I：

10.1097/01.tp.0000287126.12083.48

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Interleukin-23 (IL-23) and the recently discovered Th17 cells have been implicated in the pathogenesis of autoimmune diseases. This review will discuss current understanding of T-cell subsets in transplantation immunity and will explore the role of IL-23 and Th 17 cells in allograft rejection, tolerance, and ischemia reperfusion injury.

引用

页码：1071 / 1074

页数：4

共 42 条

[1] Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 [J].

Aggarwal, S ;

Ghilardi, N ;

Xie, MH ;

de Sauvage, FJ ;

Gurney, AL .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (03) :1910-1914

[2]

Antonysamy MA, 1999, J IMMUNOL, V162, P577

[3] Evidence for a role of IL-17 in alloimmunity: A novel IL-17 antagonist promotes heart graft survival [J].

Antonysamy, MA ;

Fanslow, WC ;

Fu, F ;

Li, W ;

Qian, S ;

Troutt, AB ;

Thomson, AW .

TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) :93-93

[4] Islet allograft rejection can be mediated by CD4+ alloantigen experienced, direct pathway T cells of Th1 and Th2 cytokine phenotype [J].

Barbara, JAJ ;

Turvey, SE ;

Kingsley, CI ;

Spriewald, BM ;

Hara, M ;

Witzke, O ;

Morris, PJ ;

Wood, KJ .

TRANSPLANTATION, 2000, 70 (11) :1641-1649

[5] Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].

Bettelli, E ;

Carrier, YJ ;

Gao, WD ;

Korn, T ;

Strom, TB ;

Oukka, M ;

Weiner, HL ;

Kuchroo, VK .

NATURE, 2006, 441 (7090) :235-238

[6] New cellular and molecular immune pathways in ischemia/reperfusion injury [J].

Boros, P ;

Bromberg, JS .

AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (04) :652-658

[7] Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis [J].

Chen, Y ;

Langrish, CL ;

Mckenzie, B ;

Joyce-Shaikh, B ;

Stumhofer, JS ;

McClanahan, T ;

Blumenschein, W ;

Churakovsa, T ;

Low, J ;

Presta, L ;

Hunter, CA ;

Kastelein, RA ;

Cua, DJ .

JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (05) :1317-1326

[8]

Ferber IA, 1996, J IMMUNOL, V156, P5

[9] T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis [J].

Hirota, Keiji ;

Hashimoto, Motomu ;

Yoshitomi, Hiroyuki ;

Tanaka, Satoshi ;

Nomura, Takashi ;

Yamaguchi, Tomoyuki ;

Iwakura, Yoichiro ;

Sakaguchi, Noriko ;

Sakaguchi, Shimon .

JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (01) :41-47

[10] Interleukin-23 drives innate and T cell-mediated intestinal inflammation [J].

Hue, Sophie ;

Ahern, Philip ;

Buonocore, Sofia ;

Kullberg, Marika C. ;

Cua, Daniel J. ;

McKenzie, Brent S. ;

Powrie, Fiona ;

Maloy, Kevin J. .

JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (11) :2473-2483

← 1 2 3 4 5 →